BSEAGM/EGM3d ago · 10 Aug 2026, 12:25 pm
We wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain unavoidable ....
Suraksha Diagnostic Ltd · 544293
✦ AI Summary
Suraksha Diagnostic Ltd has postponed its 21st Annual General Meeting (AGM) scheduled for September 2, 2026, due to unavoidable circumstances. The revised date, time, and venue will be announced later, in accordance with applicable laws and regulations.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Suraksha Diagnostic Ltd - 544293 - Intimation Of Postponement Of The 21St Annual General Meeting Of The Company
Attachments (1)
📄pdf
Download →
3cc7ee9a-6599-49d6-9bee-ff9e4f26b4bd.pdf
View document text
Date: 10 August 2026
The Secretary The Secretary
BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block
Dalal Street Bandra -Kurla Complex, Bandra (East)
Mumbai - 400 001 Mumbai- 400 051
Scrip Code: 544293 Scrip Symbol : SURAKSHA
Dear Sir / Ma’am,
Subject: Intimation of postponement of the 21st Annual General Meeting of the Company.
Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, and in continuation of our earlier intimation letter dated 21 May 2026, we wish to
inform you that the 21st Annual General Meeting (“AGM”) of the Company, which was scheduled to
be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain
unavoidable circumstances. The revised date, time and venue for holding the 21st AGM will be decided
in due course, accordance with the applicable provisions of the Companies Act, 2013 read with rules
made thereunder and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
and the same shall be informed to the Stock Exchanges and shareholders accordingly.
We request you to take the above on record. The Company regrets any inconvenience caused to the
shareholders on account of the aforesaid postponement.
Thanking you.
For Suraksha Diagnostic Limited
Ritu Mittal
Joint Managing Director & CEO
DIN: 00165886
Encl.: as above
Suraksha Diagnostic Limited
(Formerly known as Suraksha Diagnostic Private Limited)
CIN: L85110WB2005PLC102265
Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New
Town, Kolkata-700 156, West Bengal, India
E-mail: investors@surakshanet.com I Website: www.surakshanet.com
Phone:(033) 6605 9750